Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousCrohn DiseaseTransplantation ConditioningPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationStem CellsLiver TransplantationGraft vs Host DiseaseKidney TransplantationMultiple MyelomaHematologic NeoplasmsGraft SurvivalTreatment OutcomeHematopoietic Stem CellsCell TransplantationMelphalanHematopoietic Stem Cell MobilizationCombined Modality TherapyTransplantation ChimeraTissue DonorsRecurrenceHeart TransplantationMesenchymal Stem Cell TransplantationCord Blood Stem Cell TransplantationWhole-Body IrradiationBusulfanRemission InductionMyeloablative AgonistsLung TransplantationAntigens, CD34Retrospective StudiesSalvage TherapyImmunosuppressive AgentsLymphoma, Non-HodgkinCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalSurvival AnalysisHistocompatibility TestingOrgan TransplantationSurvival RateEmbryonic Stem CellsTransplantation ImmunologyGraft RejectionGranulocyte Colony-Stimulating FactorTime FactorsCarmustineBone Marrow PurgingLeukapheresisAdult Stem CellsGraft vs Tumor EffectHistocompatibilityLeukemiaIslets of Langerhans TransplantationTransplantationHodgkin DiseaseFollow-Up StudiesCell DifferentiationEtoposideTransplantation, IsogeneicCytarabinePancreas TransplantationLeukemia, Myeloid, AcuteGraft vs Leukemia EffectMyelodysplastic SyndromesHematopoiesisPrognosisBone Marrow CellsVidarabinePluripotent Stem CellsLiving DonorsImmunosuppressionCells, CulturedMesenchymal Stromal CellsHLA AntigensNeural Stem CellsBone MarrowHepatic Veno-Occlusive DiseaseNeoplasm, ResidualStem Cell NicheChimerismVincristineCell SeparationLymphocyte TransfusionHematologic DiseasesLymphomaSiblingsFlow CytometryAntineoplastic Agents, AlkylatingTransplantation ToleranceAntilymphocyte SerumInduced Pluripotent Stem CellsProspective StudiesBlood Transfusion, AutologousCell Culture TechniquesBlood Component RemovalTransplantation, Heterotopic